Envista Holdings Corp current report, 31 August 2023

Business Context and Reporting Period

Envista Holdings Corporation filed this Form 8-K regarding a material financing transaction entered into on August 31, 2023. The filing does not report operating results for a quarterly or annual period.

Material Financing and Key Financial Metrics

  • Envista entered into a Second Amended and Restated Credit Agreement with a syndicate of banks, with Bank of America, N.A. serving as administrative agent.
  • The maturity date for the U.S. dollar term facility, euro term facility, and revolving credit facility was extended to August 31, 2028, subject to an earlier springing maturity date 91 days before the maturity of the company’s 1.75% convertible senior notes due 2028 if more than $250 million of those notes remain outstanding.
  • The new facilities include a $530 million U.S. dollar term loan, a €350 million euro term loan, and $750 million of revolving credit commitments.
  • Proceeds will refinance indebtedness under the prior credit agreement and fund general corporate purposes and other permitted uses.
  • Except as specified in the amended agreement, interest rates applicable to the term loans and revolving facility remain unchanged. The spread adjustment for Term SOFR-based loans is fixed at 10 basis points for all interest periods.
  • Envista paid approximately $4.7 million in fees related to the amended credit agreement.
  • The agreement includes customary representations, covenants, and events of default substantially similar to those in the prior credit agreement.

Changes Versus the Prior Comparable Agreement

  • The agreement amends and restates the existing amended and restated credit agreement dated June 15, 2021.
  • The principal changes are the extension of facility maturities, establishment of new U.S. dollar and euro term loans, continuation of revolving commitments, and refinancing of existing debt.
  • The filing text does not provide the outstanding balances or interest rates under the prior agreement, so the net change in total debt and borrowing costs cannot be determined from this filing alone.

Outlook, Risks, and Unusual Items

  • The facilities provide additional financing capacity through the $750 million revolving credit commitments, subject to the agreement’s terms and conditions.
  • The springing maturity provision creates refinancing or liquidity risk if more than $250 million of the 2028 convertible senior notes remain outstanding near the facility maturity date.
  • Customary financial and other covenants, representations, and events of default apply; the filing does not provide the detailed covenant thresholds.
  • The approximately $4.7 million of financing fees is a one-time transaction-related cost identified in the filing.
  • No revenue, earnings, cash flow, margin, or management operating guidance was provided.

Important Facts for Investors to Verify

  • Review Exhibit 10.1 for the complete credit agreement, including interest-rate margins, covenant requirements, mandatory prepayments, collateral, and events of default.
  • Verify the accounting treatment and amortization of the approximately $4.7 million in financing fees.
  • Assess total debt, currency exposure, and liquidity after refinancing using the company’s subsequent periodic filings.
  • Monitor the amount outstanding under the 1.75% convertible senior notes due 2028 and the potential impact of the springing maturity provision.
  • Confirm actual borrowings, availability, and compliance with credit agreement covenants in subsequent reports.